Serial Number 90207084
Registration 7324719
700

Registration Progress

Application Filed
Sep 24, 2020
Under Examination
Aug 22, 2023
Approved for Publication
Jun 27, 2023
Published for Opposition
Jun 27, 2023
Registered
Mar 12, 2024

Trademark Image

Basic Information

Serial Number
90207084
Registration Number
7324719
Filing Date
September 24, 2020
Registration Date
March 12, 2024
Published for Opposition
June 27, 2023
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 12, 2024
Registration
Registered
Classes
005 035 039 040
+4 more

Rights Holder

Cellex Cell Professionals GmbH

99
Address
Im Mediapark 6b
Cologne 50670
DE

Ownership History

Cellex Cell Professionals GmbH

Original Applicant
99
Cologne DE

Cellex Cell Professionals GmbH

Owner at Publication
99
Cologne DE

Cellex Cell Professionals GmbH

Original Registrant
99
Cologne DE

Legal Representation

Attorney
Stacy L. Emhoff

USPTO Deadlines

Next Deadline
1503 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240312)
Due Date
March 12, 2030
Grace Period Ends
September 12, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

41 events
Date Code Type Description Documents
Mar 12, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Mar 12, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 1, 2024 DP1B I 1(B) BASIS DELETED; PROCEED TO REGISTRATION Loading...
Dec 5, 2023 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
Feb 1, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 5, 2023 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
Aug 22, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 27, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 27, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 7, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 23, 2023 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
May 16, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 15, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 14, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 14, 2023 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
May 14, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
May 14, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Feb 14, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Feb 14, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Feb 14, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
Dec 22, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 22, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 19, 2022 ALIE A ASSIGNED TO LIE Loading...
Oct 27, 2022 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
May 17, 2022 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
May 17, 2022 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
May 17, 2022 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
May 13, 2022 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Sep 21, 2021 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Sep 21, 2021 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Sep 21, 2021 CNSL R SUSPENSION LETTER WRITTEN Loading...
Aug 17, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 16, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 16, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 17, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 17, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 17, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 12, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 4, 2020 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 3, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 28, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for monoclonal antibody therapies and treatments; Monoclonal antibody therapies for therapeutic purposes, being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; Preparations and substances for medical and pharmaceutical use comprising monoclonal antibodies and/or derivatives thereof for treatment of cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases and other pathologies, treatable or improvable through use of antibodies that bind to, activate or block the target antigens; Monoclonal antibodies for medical treatment and for diagnostics to bind or mask biological molecules in blood, serum plasma or tissue; Blood for medical purposes; Blood plasma
Class 035
Business administrative services for medical referrals to medical specialists; Maintaining a registry of blood stem cell donors and bone marrow donors to facilitate bone marrow, organ, and blood stem cell transplant services for others
Class 039
Arranging of passenger transportation services for patients who need treatment by medical specialists
Class 040
Cryopreservation services; Cryopreservation of stem cell, bone marrow and cell products, donor blood and pharmaceutical substances
Class 042
Medical research services, namely, the carrying out of and coordination of pharmacological studies for third parties to determine if a research topic is worth pursuing by conducting preparatory experiments on stem cells, monoclonal antibodies, mRNA samples and on living organs; Medical research services, namely, the carrying out of and coordination of studies for medical treatment for third parties to assess planned treatments for desired effects and unwanted side effects by conducting medical tests, conducting diagnosis, collecting anamnesis data, and monitoring individuals for wanted effects and unwanted side effects of a proposed medical treatment, all of the foregoing for medical research purposes
Class 043
Services of a travel agency, namely, making hotel reservations for stem cell donors, bone marrow donors and patients as a service for third parties
Class 044
Physician services; Medical clinics; Oncology clinic, namely, radiation oncology services; Providing medical consultation regarding the special medical treatment needs of patients and providing medical advice regarding what medical specialists are needed for that medical treatment; medical consultation in the field of matching third party stem cell donors who are medically prepared for donating stem cells with stem cell receptors; Medical services, namely, the removal and collection of human cells from others that are sent to third parties for processing; Medical services, namely, the coordination of the stem cell donation with stem cell donors and stem cell recipients; Performing apheresis blood collection for the collection of stem cells for third parties
Class 045
Providing case management services, namely, coordinating medical services for patients who need treatment by medical specialists

Additional Information

Design Mark
The mark consists of a red shape and an orange shape that are positioned to look like a twisted loop.
Color Claim
The color(s) red and orange is/are claimed as a feature of the mark.

Classification

International Classes
005 035 039 040 042 043 044 045